In the fast-changing world of antiviral research, scientists are working on some exciting new medicines to help treat viral infections. Here are some of the hopeful candidates:
Remdesivir: This medicine was first created to treat Ebola but has also shown to work against COVID-19. It stops the virus from making more copies of itself.
Favipiravir: This is a general antiviral that can fight off several RNA viruses, including the flu and coronaviruses. It works by blocking a key part of the virus needed for its replication.
Nirmatrelvir: This medicine is used with another called Ritonavir to treat COVID-19. It specifically targets an important enzyme in the virus, messing up its lifecycle.
Sofosbuvir: This was originally made for hepatitis C but can also be used for other RNA viruses by stopping the virus from creating its RNA.
REGN-COV2: This treatment combines two monoclonal antibodies (casirivimab and imdevimab). It focuses on the spike protein of SARS-CoV-2, which helps the virus enter human cells. By blocking this, it helps the immune system fight off the virus.
Tocilizumab: Mostly known as an arthritis drug, it is being studied to see if it can help change how the immune system reacts in serious cases of COVID-19.
The future of antiviral treatment looks promising. Ongoing research is likely to discover even more advanced medicines. By understanding how viruses work and how our bodies respond, scientists are creating more effective ways to fight these infections.
In the fast-changing world of antiviral research, scientists are working on some exciting new medicines to help treat viral infections. Here are some of the hopeful candidates:
Remdesivir: This medicine was first created to treat Ebola but has also shown to work against COVID-19. It stops the virus from making more copies of itself.
Favipiravir: This is a general antiviral that can fight off several RNA viruses, including the flu and coronaviruses. It works by blocking a key part of the virus needed for its replication.
Nirmatrelvir: This medicine is used with another called Ritonavir to treat COVID-19. It specifically targets an important enzyme in the virus, messing up its lifecycle.
Sofosbuvir: This was originally made for hepatitis C but can also be used for other RNA viruses by stopping the virus from creating its RNA.
REGN-COV2: This treatment combines two monoclonal antibodies (casirivimab and imdevimab). It focuses on the spike protein of SARS-CoV-2, which helps the virus enter human cells. By blocking this, it helps the immune system fight off the virus.
Tocilizumab: Mostly known as an arthritis drug, it is being studied to see if it can help change how the immune system reacts in serious cases of COVID-19.
The future of antiviral treatment looks promising. Ongoing research is likely to discover even more advanced medicines. By understanding how viruses work and how our bodies respond, scientists are creating more effective ways to fight these infections.